Key facts
- It has raised $800K; the latest was PE Growth/Expansion ($800K) in Dec 2025.
- Notable investors include Motilal Oswal Real Estate Investment Advisors.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Sensa Core
- ·The full record, as it builds
Funding rounds
No funding rounds for Sensa Core are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sensa Core
Manufacturer of medical diagnostics instruments designed intended to supply customers with the cost-effective, quality-engineered in-vitro diagnostics products, without sacrificing service, speed, or reliability. The company's range of products includes blood gas analyzers, electrolyte analyzers, glucose meters, a generic portfolio, lactate meters, and others, enabling hospitals, pathological laboratories, OEM clients, and patients to get advanced analytical and diagnostic analyzers and hand-held devices, which improve patient outcomes and reduce the cost of medical and healthcare services.
- Sector
- Healthcare
- HQ
- Hyderabad, India
- Founded
- 2006
- Employees
- 350
- Website
- sensacore.com/
- Ownership
- Privately Held (backing)
Sensa Core doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sensa Core shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sensa Core in its N-PORT filings yet. We sweep new filings monthly.